Pfizer Torcetrapib Class Action Lawsuit
Schoengold Sporn Laitman & Lometti, P.C. has announced that the firm has filed a class action lawsuit against Pfizer Inc.
The complaint alleges that defendants made materially false and misleading statements to artificially inflate the value of Pfizer stock. Specifically, it is alleged that beginning in July 2006, the defendants repeatedly touted the safety and effectiveness of torcetrapib.
Schoengold Sporn Laitman & Lometti alleges that "These statements were false and misleading when made because the defendants failed to disclose or indicate that they knew that the torcetrapib was having adverse affects on patients' health."
More info here.